Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.

× No keyword cloud information.

29 in total

Review 1. [Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].

Authors: G Horneff
Journal: Z Rheumatol Date: 2010-08 Impact factor: 1.372

Review 2. Safety of biologic therapy in rheumatoid arthritis.

Authors: Robert S Woodrick; Eric M Ruderman
Journal: Nat Rev Rheumatol Date: 2011-10-11 Impact factor: 20.543

3. [Updated statement by the German Society for Pediatric and Adolescent Rheumatology (GKJR) on the FDA's report regarding malignancies in anti-TNF-treated patients from Aug. 4, 2009].

Authors: G Horneff; T Hospach; G Dannecker; D Föll; J P Haas; H J Girschick; H I Huppertz; R Keitzer; H J Laws; H Michels; K Minden; R Trauzeddel
Journal: Z Rheumatol Date: 2010-08 Impact factor: 1.372

Review 4. Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.

Authors: Meenakshi Bewtra; F Reed Johnson
Journal: Patient Date: 2013 Impact factor: 3.883

Review 5. Update on the management of Crohn's disease.

Authors: Anna M Buchner; Wojciech Blonski; Gary R Lichtenstein
Journal: Curr Gastroenterol Rep Date: 2011-10

6. Specialized enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis.

Authors: Douglas L Nguyen; Lena B Palmer; Emily T Nguyen; Stephen A McClave; Robert G Martindale; Matthew L Bechtold
Journal: Therap Adv Gastroenterol Date: 2015-07 Impact factor: 4.409

7. Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-tumour necrosis factor-α therapy.

Authors: J Kelsen; A Dige; M Christensen; F D'Amore; L Iversen
Journal: Clin Exp Immunol Date: 2014-07 Impact factor: 4.330

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.